Title: Establishment of Public Cord Blood Banks – The Need of the Hour in India

Authors: Suriya Narayanan S, Jaianand Kannaiyan, Palaniyandi M, Rajangam B, Bhavna A, Anubhav Pandey

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i1.09

Abstract

Since, the first successful transplantation of umbilical cord blood in 1988, marking 25th anniversary of the first umbilical cord blood transplantation performed in France, in a child with Fanconi Anemia, umbilical cord blood transplantation is considered as an alternative to hematopoietic stem cell source for patients with hematologic diseases. With over 600,000 umbilical cord blood units stored for transplantation worldwide and over 30,000 umbilical cord blood transplantation performed, the patient pool in India treated with umbilical cord blood transplant using related or unrelated is merely only 32. In a country, where private cord blood banking has a significant attention and considering the large number of patients born with blood related disorders, these transplantations are comparatively few. In this paper, we review the need of setting up of a public cord blood bank across the country, lack of sufficient umbilical cord blood repository, therapeutic challenges associated with umbilical cord blood with an increase in hematological diseases incidence in India.

Keywords- Private cord blood banks; Public cord blood banks; Stem cell transplantation; Umbilical cord blood banking.

References

1.      Appelbaum FR. Pursuing the goal of a donor for everyone in need. N Engl J Med. 2012; 367(16):1555-1556.

2.      Chandra V, Arunava R, Devi D, Arun Kumar M, Preeti K. Optimization of the Inventory size of the Public cord blood program- The Indian context. The Journal of the Association of Physicians of India. 2010; 58: 608-611

3.      Pitchappan RM, Kavitha, Jayalakshmi M. HLA genomic diversity of India and its implications in HIV pandemic. Intl J Hum Genet. 2008; 8: 143-153.

4.      Broxmeyer HE, Douglas GW, Hangoc G, Copper S, Bard J et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progen-itor cells. Proc Natl Acad Sci. 1988; 86(10): 3828-3832.

5.      Eliane Gluckman, Broxmeyer Hal E, Arleen D, Auerbach, Henry S et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA identified sibling. N  Engl J Med. 1989; 32(17): 1174-1178.

6.      Ramnath Takiar, Deenu Nadayil, Nandakumar. Projections of Number of Cancer Cases in India (2010-2020) by Cancer Groups. Asian Pacific Journal of Cancer Prevention.  2010; 11:1045-1049.

7.      Beatty PG, Boucher KM, Milford EL. Prob-ability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Human Immunology 2000; 61:834-40.

8.      Mckenna D, Sheth J. Umbilical cord blood: Current status & promise for the future. Indian J Med Res 2011; 134:261-9.

9.      Clea Caulcutt, Tom Cochez. Working grant - International Offensive on Cord Blood Banking; Journalismfund.eu. File number: 2010/010.

10.  Ethical aspects of umbilical cord blood banking: Opinion of the European Group of Ethics in Science and new Technologies to the European Commission. No 19; 2004.

11.  McCullough J, McKenna D, Kadidlo D, Schierman T, Wagner J. Issues in the quality of umbilical cord blood stem cells for trans-plantation. Transfusion. 2005;45:832–41. 

12.  Armson BA. Maternal Fetal Medicine Committee, Society of Obstetricians and Gynecologists of Canada. Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can. 2005;27:263–90.

13.  Ballen KK, Veter F, Kurtzberg J. Umbilical cord blood donation: public or private? Bone Marrow Transplantation. 2015, 1-8.

14.  Tomblyn MB, Arora M, Baker KS, et al. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. Journal Clinical Oncology 2009; 27: 3634-41.

15.  Jaing TH, Yang CP, Hung IJ, et al. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion dependant Thalassemia. Bone Marrow Transplant 2007; 40: 307-11. 

Corresponding Author

Dr. Anubhav Pandey

Medical Director, CelluGen Biotech Private Limited, CelluGen House, 62, Udyog Vihar Phase-1,

Gurgaon- 122016, Haryana, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Contact: +91-7838515178